BLOOMLIFE
San Francisco, US · Founded 2014 · Delaware corporation · 7 known investors
Bloomlife offers a remote patient monitoring platform for high-risk pregnancy care, giving clinical teams customizable protocols and smart notifications to identify at-risk patients and address potential complications early. The product is aimed at healthcare providers managing high-risk patient populations.
Founders & leadership
JP
Julien PendersExecutive Officer, Director
ED
Eric DyExecutive Officer, Director
YS
Young SohnDirector
MM
Max MirgoliDirector
LL
Lucio LanzaDirector
UO
Uriridiakoghene OnovakpuriDirector
XP
Xavier PetersDirector
CO
Charlotte OwensDirector
Investors · 7
Reported raises · per SEC filings
Form D private placements▶$12.9MraisedSep 2024 · 50 investors · Other TechnologyRule 506(b)
▶$12.9MraisedSep 2024 · 50 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Charlotte OwensDirector
- Julien PendersExecutive Officer, Director
- Uriridiakoghene OnovakpuriDirector
- Eric DyExecutive Officer, Director
- Xavier PetersDirector
- Offering amount
- $14.9M
- Amount sold
- $12.9M
- First sale
- Aug 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8.1MraisedOct 2017 · 37 investors · Other TechnologyRule 506(b)
▶$8.1MraisedOct 2017 · 37 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Eric DyExecutive Officer, Director
- Young SohnDirector
- Max MirgoliDirector
- Julien PendersExecutive Officer, Director
- Lucio LanzaDirector
- Offering amount
- $8.9M
- Amount sold
- $8.1M
- First sale
- Oct 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.